Current technology based on ELISA
Technology
iSCOR
iSCOR is based on novel and proprietary monoclonal antibodies against specific glycosylated epitopes on human ApoJ protein sequence
iSCOR highlights
Monoclonal antibody technology allows standardization and upscaling
Marker with high concentration not requiring high sensitivity assays
Adaptable to standard platforms currently being used in cardiac marker testing and Point-of-Care detection technologies
Several potential uses confirmed by cardiologists and A&E experts: pre-hospital, intra-hospital and post-discharge follow-up settings
Let's get in touch
